Cargando…
Multiple sclerosis: Possible immunological mechanisms()
Multiple sclerosis is the principal demyelinating disease of the central nervous system. Although the prevalence of the disease is moderately low, averaging about 40 cases per 100,000 people in high risk areas, it is a particularly devastating disease. It primarily affects young adults, is chronic,...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
1989
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133204/ https://www.ncbi.nlm.nih.gov/pubmed/2521315 http://dx.doi.org/10.1016/0090-1229(89)90116-5 |
_version_ | 1783517580358582272 |
---|---|
author | McFarland, Henry F. Dhib-Jalbut, Suhayl |
author_facet | McFarland, Henry F. Dhib-Jalbut, Suhayl |
author_sort | McFarland, Henry F. |
collection | PubMed |
description | Multiple sclerosis is the principal demyelinating disease of the central nervous system. Although the prevalence of the disease is moderately low, averaging about 40 cases per 100,000 people in high risk areas, it is a particularly devastating disease. It primarily affects young adults, is chronic, and has an unpredictable course. Most discouraging, the cause of the disease is not known and an effective treatment has not been identified. Recently, however, research has yielded some important findings concerning the etiology of MS. Much evidence now points to an immunological process as one of the major elements in the disease. It is also likely that an environmental influence, possibly an infectious process, may contribute to the disease. Finally, it is now certain that genetic makeup influences susceptibility to the disease. At present, the strongest evidence is for a polygenic effect, not the effect of a single gene or gene locus. This review will examine some of the possible immunologically mediated disease processes that could be involved in MS, especially those that could account for a role for infectious and genetic factors in the disease. |
format | Online Article Text |
id | pubmed-7133204 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1989 |
publisher | Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71332042020-04-08 Multiple sclerosis: Possible immunological mechanisms() McFarland, Henry F. Dhib-Jalbut, Suhayl Clin Immunol Immunopathol Article Multiple sclerosis is the principal demyelinating disease of the central nervous system. Although the prevalence of the disease is moderately low, averaging about 40 cases per 100,000 people in high risk areas, it is a particularly devastating disease. It primarily affects young adults, is chronic, and has an unpredictable course. Most discouraging, the cause of the disease is not known and an effective treatment has not been identified. Recently, however, research has yielded some important findings concerning the etiology of MS. Much evidence now points to an immunological process as one of the major elements in the disease. It is also likely that an environmental influence, possibly an infectious process, may contribute to the disease. Finally, it is now certain that genetic makeup influences susceptibility to the disease. At present, the strongest evidence is for a polygenic effect, not the effect of a single gene or gene locus. This review will examine some of the possible immunologically mediated disease processes that could be involved in MS, especially those that could account for a role for infectious and genetic factors in the disease. Published by Elsevier Inc. 1989-01 2004-02-04 /pmc/articles/PMC7133204/ /pubmed/2521315 http://dx.doi.org/10.1016/0090-1229(89)90116-5 Text en Copyright © 1989 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article McFarland, Henry F. Dhib-Jalbut, Suhayl Multiple sclerosis: Possible immunological mechanisms() |
title | Multiple sclerosis: Possible immunological mechanisms() |
title_full | Multiple sclerosis: Possible immunological mechanisms() |
title_fullStr | Multiple sclerosis: Possible immunological mechanisms() |
title_full_unstemmed | Multiple sclerosis: Possible immunological mechanisms() |
title_short | Multiple sclerosis: Possible immunological mechanisms() |
title_sort | multiple sclerosis: possible immunological mechanisms() |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133204/ https://www.ncbi.nlm.nih.gov/pubmed/2521315 http://dx.doi.org/10.1016/0090-1229(89)90116-5 |
work_keys_str_mv | AT mcfarlandhenryf multiplesclerosispossibleimmunologicalmechanisms AT dhibjalbutsuhayl multiplesclerosispossibleimmunologicalmechanisms |